soul trial oral semaglutide cardiovascular outcomes 2024 results nejm Reduces CV Events in T2DM β (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine π§ͺ T2DM + ASCVD/CKD π Oral semaglutide 14 mg vs placebo π The impact of oral semaglutide
Description
Thats another reason theyre not going to see the long-term effects. Diede agreed that, at current prices, the economics are difficult to justify purely on cost savings
-$2M(-2M) Debt/Value 4 Includes stadium debt and is based on May 14
These medications are especially helpful when diet and exercise alone are not sufficient
interestingly, GLP-1 users lost weight, while control groups gained
The proglucagon gene (gcg) encodes for glucagon as well as two glucagon-like peptides, GLP-1 and GLP-2 (25, 26)
And Amber, thank you so much
